Tikvah Management LLC Mesoblast LTD Transaction History

Tikvah Management LLC

  • $303 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$8.26 - $11.4 $1.18 Million - $1.63 Million
-142,890 Closed
0 $0
Q4 2020

Feb 17, 2021
SELL
$8.21 - $18.59 $5,927 - $13,421
-722 Reduced 0.5%
142,890 $1.21 Million
Q3 2020

Nov 16, 2020
BUY
$11.33 - $19.81 $1.63 Million - $2.84 Million
143,612 New
143,612 $2.67 Million

Others Institutions Holding MESO

# of Institutions
3
Shares Held
151K
Call Options Held
0
Put Options Held
0
View Full List

About MESOBLAST LTD

MESO Quotes by TradingView
  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.2B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Tikvah Management LLC Portfolio

Follow Tikvah Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tikvah Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tikvah Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email